Priming tumor vaccine draining lymph node T cells by GM-CSF transduced 4T1

被引：0
|
作者：
Jensen, SM
Hu, HM
Fox, BA
机构：
[1] Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
[2] Oregon Grad Inst, Dept Biochem & Mol Biol, Portland, OR USA
来源：
FASEB JOURNAL | 2000年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1008 / A1008
页数：1
相关论文
共 50 条
  • [1] Breast cancer: Draining lymph node of vaccination site targeted by adjuvant GM-CSF in an autologous vaccine
    Garcia-Giralt, E.
    Lasalvia-Prisco, E.
    Cucchi, S.
    Aghazarian, M.
    Larranaga, J.
    Brent, M.
    Walton, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene
    Chang, AE
    Sondak, VK
    Bishop, DK
    Nickoloff, BJ
    Mulligan, RC
    Mule, JJ
    HUMAN GENE THERAPY, 1996, 7 (06) : 773 - 792
  • [3] Inhibition of 4T1 mammary tumor growth in BALB/c mice by subcutaneous and intraperitoneal injection of a 4T1 whole cell vaccine containing IL-2 and GM-CSF as adjuvants
    Head, Jonathan F.
    Phillips, Jeffrey T.
    Jiang, Xianpeng
    Elliott, Robert L.
    CANCER RESEARCH, 2017, 77
  • [4] Efficacies of IFN-gamma, GM-CSF or MCP-1 gene transduced melanoma cells as tumor vaccine.
    Ogawa, T
    Nagai, E
    Suzuki, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 185 - 185
  • [5] In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1
    Gravekamp, Claudia
    Leal, Belinda
    Denny, Ashley
    Bahar, Rumana
    Lampkin, Shellye
    Castro, Francisco
    Kim, Sun Hee
    Moore, Dan
    Reddick, Robert
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (07) : 1067 - 1077
  • [6] In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1
    Claudia Gravekamp
    Belinda Leal
    Ashley Denny
    Rumana Bahar
    Shellye Lampkin
    Francisco Castro
    Sun Hee Kim
    Dan Moore
    Robert Reddick
    Cancer Immunology, Immunotherapy, 2008, 57 : 1067 - 1077
  • [7] GM-CSF producing autoreactive CD4+ T cells in type 1 diabetes
    Knoop, Jan
    Gavrisan, Anita
    Kuehn, Denise
    Reinhardt, Julia
    Heinrich, Melanie
    Hippich, Markus
    Eugster, Anne
    Ockert, Christian
    Ziegler, Anette-Gabriele
    Bonifacio, Ezio
    CLINICAL IMMUNOLOGY, 2018, 188 : 23 - 30
  • [8] BLOCKING OF THE LTB4 SIGNALING MAINTAINS THE IN VIVO ANTITUMOR EFFECTS OF GM-CSF TRANSDUCED TUMOR CELLS
    Yokota, Yosuke
    Nabeta, Haruka
    Inoue, Hiroyuki
    Iga, Mutsunori
    Xin, Meng
    Kurita, Ryo
    Sasaki, Fumiyuki
    Takayama, Koichi
    Nakanishi, Yoichi
    Yokomizo, Takehiko
    Tani, Kenzaburo
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1172 - 1172
  • [9] Regulation of GM-CSF production by human T helper cells
    Noster, R.
    Riedel, R.
    Radbruch, A.
    Zielinski, C. E.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E32 - E32
  • [10] Signals for activation of the GM-CSF promoter and enhancer in T cells
    Shannon, MF
    Coles, LS
    Vadas, MA
    Cockerill, PN
    CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (3-4) : 301 - 323
12345